MYD88 and pulmonary arterial hypertension: The collected evidence indicates that the balance of TLRs largely determines the course and prognosis of PAH—specifically, the balance between the proinflammatory MyD88–NF-κB/IL-6 axis and the protective TRIF–IFN–α axis.